Global Bio-Therapeutic Glycoproteins Market Research Report 2019-2025

Published On: Aug 2019

Format: PDF

Publisher: QY Research

Pages: 97

Report ID: 53107

Bio-Therapeutic Glycoproteins are bioactive compounds with carbohydrates attached to proteins. Glycan is the specific site where carbohydrate attaches to proteins and process of production is called glycosylation. Bio-therapeutic glycoproteins produced with glycan moieties that are similar to natural mammal glycans. The most common types are glycosylation O-linked and N-linked that are mainly depends on protein sequence attachment. Carbohydrates linked to proteins through either α and β linkages. Glycosylation is an important process of bio-therapeutic glycoproteins because it is critically modulated into bioactivity, stability, solubility against proteolysis, yield, clearance rate from circulation and immunogenicity. The bio-therapeutic glycoproteins mainly produced by yeast expression systems, insect cells, mammalian systems, and plant-based expression systems. In yeast expression systems, yeast is cultured chemically to scale up fermentation to an industrial level. Yeast and human share same N-glycan's linkage. Insect cells represent an alternative system for expression of recombinant bio-therapeutic proteins. Later recombinant proteins are separated from insect cells. Mammalian Systems are used to produce complex bio-therapeutic glycoproteins. Most of the FDA approved bio-therapeutic glycoproteins derived from mammalian systems. Plant-based expression systems used for the scale-up production of glycoproteins. Among all systems, mammalian systems are well established in pharmaceuticals. Some examples of bio-therapeutic glycoproteins include tocilizumab, bevacizumab, adalimumab, etc.
The potential benefits of Bio-Therapeutic Glycoproteins have been a subject of rising industrial interest in the context of wide range application. So, far they include several protein classes like antisera, cytokines, clotting factors, hormones, enzymes and enzyme inhibitors have been best suited physiologically. The trend of industrial developments likely continues alongside with growing knowledge about the functions of bio-therapeutic glycoproteins. Bio-Therapeutic Glycoproteins are a fastest growing field in the pharmaceutical industry due to a wide range of applicability. The mammalian expression system is used to produce glycoproteins that coded with human-like glycans. Bio-Therapeutic glycoproteins represent an integrated treatment for most of the autoimmune disorders, cancers, replacement therapies like hormone and enzyme substituted. All these benefits of glycoproteins drive the robust growth of the Bio-Therapeutic Glycoproteins market.

The global Bio-Therapeutic Glycoproteins market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Bio-Therapeutic Glycoproteins volume and value at global level, regional level and company level. From a global perspective, this report represents overall Bio-Therapeutic Glycoproteins market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:
Genentech
Hoffmann-La Roche
Genzyme Corp
Abbott Laboratories
Amgen
Biogen
Merck
GlaxoSmithKline
Novartis Pharmaceuticals Corp

Segment by Regions
North America
Europe
China
Japan

Segment by Type
Antisera
Cytokines
Clotting Factors
Hormones
Enzymes
Enzyme Inhibitors

Segment by Application
Oncology and Haematology
Diabetes
Cardiology
Inflammatory Diseases
Others

Table of Contents

Executive Summary
1 Bio-Therapeutic Glycoproteins Market Overview
1.1 Product Overview and Scope of Bio-Therapeutic Glycoproteins
1.2 Bio-Therapeutic Glycoproteins Segment by Type
1.2.1 Global Bio-Therapeutic Glycoproteins Production Growth Rate Comparison by Type (2014-2025)
1.2.2 Antisera
1.2.3 Cytokines
1.2.4 Clotting Factors
1.2.5 Hormones
1.2.6 Enzymes
1.2.7 Enzyme Inhibitors
1.3 Bio-Therapeutic Glycoproteins Segment by Application
1.3.1 Bio-Therapeutic Glycoproteins Consumption Comparison by Application (2014-2025)
1.3.2 Oncology and Haematology
1.3.3 Diabetes
1.3.4 Cardiology
1.3.5 Inflammatory Diseases
1.3.6 Others
1.4 Global Bio-Therapeutic Glycoproteins Market by Region
1.4.1 Global Bio-Therapeutic Glycoproteins Market Size Region
1.4.2 North America Status and Prospect (2014-2025)
1.4.3 Europe Status and Prospect (2014-2025)
1.4.4 China Status and Prospect (2014-2025)
1.4.5 Japan Status and Prospect (2014-2025)
1.5 Global Bio-Therapeutic Glycoproteins Market Size
1.5.1 Global Bio-Therapeutic Glycoproteins Revenue (2014-2025)
1.5.2 Global Bio-Therapeutic Glycoproteins Production (2014-2025)

2 Global Bio-Therapeutic Glycoproteins Market Competition by Manufacturers
2.1 Global Bio-Therapeutic Glycoproteins Production Market Share by Manufacturers (2014-2019)
2.2 Global Bio-Therapeutic Glycoproteins Revenue Share by Manufacturers (2014-2019)
2.3 Global Bio-Therapeutic Glycoproteins Average Price by Manufacturers (2014-2019)
2.4 Manufacturers Bio-Therapeutic Glycoproteins Production Sites, Area Served, Product Types
2.5 Bio-Therapeutic Glycoproteins Market Competitive Situation and Trends
2.5.1 Bio-Therapeutic Glycoproteins Market Concentration Rate
2.5.2 Bio-Therapeutic Glycoproteins Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion

3 Global Bio-Therapeutic Glycoproteins Production Market Share by Regions
3.1 Global Bio-Therapeutic Glycoproteins Production Market Share by Regions
3.2 Global Bio-Therapeutic Glycoproteins Revenue Market Share by Regions (2014-2019)
3.3 Global Bio-Therapeutic Glycoproteins Production, Revenue, Price and Gross Margin (2014-2019)
3.4 North America Bio-Therapeutic Glycoproteins Production
3.4.1 North America Bio-Therapeutic Glycoproteins Production Growth Rate (2014-2019)
3.4.2 North America Bio-Therapeutic Glycoproteins Production, Revenue, Price and Gross Margin (2014-2019)
3.5 Europe Bio-Therapeutic Glycoproteins Production
3.5.1 Europe Bio-Therapeutic Glycoproteins Production Growth Rate (2014-2019)
3.5.2 Europe Bio-Therapeutic Glycoproteins Production, Revenue, Price and Gross Margin (2014-2019)
3.6 China Bio-Therapeutic Glycoproteins Production (2014-2019)
3.6.1 China Bio-Therapeutic Glycoproteins Production Growth Rate (2014-2019)
3.6.2 China Bio-Therapeutic Glycoproteins Production, Revenue, Price and Gross Margin (2014-2019)
3.7 Japan Bio-Therapeutic Glycoproteins Production (2014-2019)
3.7.1 Japan Bio-Therapeutic Glycoproteins Production Growth Rate (2014-2019)
3.7.2 Japan Bio-Therapeutic Glycoproteins Production, Revenue, Price and Gross Margin (2014-2019)

4 Global Bio-Therapeutic Glycoproteins Consumption by Regions
4.1 Global Bio-Therapeutic Glycoproteins Consumption by Regions
4.2 North America Bio-Therapeutic Glycoproteins Consumption (2014-2019)
4.3 Europe Bio-Therapeutic Glycoproteins Consumption (2014-2019)
4.4 China Bio-Therapeutic Glycoproteins Consumption (2014-2019)
4.5 Japan Bio-Therapeutic Glycoproteins Consumption (2014-2019)

5 Global Bio-Therapeutic Glycoproteins Production, Revenue, Price Trend by Type
5.1 Global Bio-Therapeutic Glycoproteins Production Market Share by Type (2014-2019)
5.2 Global Bio-Therapeutic Glycoproteins Revenue Market Share by Type (2014-2019)
5.3 Global Bio-Therapeutic Glycoproteins Price by Type (2014-2019)
5.4 Global Bio-Therapeutic Glycoproteins Production Growth by Type (2014-2019)

6 Global Bio-Therapeutic Glycoproteins Market Analysis by Applications
6.1 Global Bio-Therapeutic Glycoproteins Consumption Market Share by Application (2014-2019)
6.2 Global Bio-Therapeutic Glycoproteins Consumption Growth Rate by Application (2014-2019)

7 Company Profiles and Key Figures in Bio-Therapeutic Glycoproteins Business
7.1 Genentech
7.1.1 Genentech Bio-Therapeutic Glycoproteins Production Sites and Area Served
7.1.2 Bio-Therapeutic Glycoproteins Product Introduction, Application and Specification
7.1.3 Genentech Bio-Therapeutic Glycoproteins Production, Revenue, Price and Gross Margin (2014-2019)
7.1.4 Main Business and Markets Served
7.2 Hoffmann-La Roche
7.2.1 Hoffmann-La Roche Bio-Therapeutic Glycoproteins Production Sites and Area Served
7.2.2 Bio-Therapeutic Glycoproteins Product Introduction, Application and Specification
7.2.3 Hoffmann-La Roche Bio-Therapeutic Glycoproteins Production, Revenue, Price and Gross Margin (2014-2019)
7.2.4 Main Business and Markets Served
7.3 Genzyme Corp
7.3.1 Genzyme Corp Bio-Therapeutic Glycoproteins Production Sites and Area Served
7.3.2 Bio-Therapeutic Glycoproteins Product Introduction, Application and Specification
7.3.3 Genzyme Corp Bio-Therapeutic Glycoproteins Production, Revenue, Price and Gross Margin (2014-2019)
7.3.4 Main Business and Markets Served
7.4 Abbott Laboratories
7.4.1 Abbott Laboratories Bio-Therapeutic Glycoproteins Production Sites and Area Served
7.4.2 Bio-Therapeutic Glycoproteins Product Introduction, Application and Specification
7.4.3 Abbott Laboratories Bio-Therapeutic Glycoproteins Production, Revenue, Price and Gross Margin (2014-2019)
7.4.4 Main Business and Markets Served
7.5 Amgen
7.5.1 Amgen Bio-Therapeutic Glycoproteins Production Sites and Area Served
7.5.2 Bio-Therapeutic Glycoproteins Product Introduction, Application and Specification
7.5.3 Amgen Bio-Therapeutic Glycoproteins Production, Revenue, Price and Gross Margin (2014-2019)
7.5.4 Main Business and Markets Served
7.6 Biogen
7.6.1 Biogen Bio-Therapeutic Glycoproteins Production Sites and Area Served
7.6.2 Bio-Therapeutic Glycoproteins Product Introduction, Application and Specification
7.6.3 Biogen Bio-Therapeutic Glycoproteins Production, Revenue, Price and Gross Margin (2014-2019)
7.6.4 Main Business and Markets Served
7.7 Merck
7.7.1 Merck Bio-Therapeutic Glycoproteins Production Sites and Area Served
7.7.2 Bio-Therapeutic Glycoproteins Product Introduction, Application and Specification
7.7.3 Merck Bio-Therapeutic Glycoproteins Production, Revenue, Price and Gross Margin (2014-2019)
7.7.4 Main Business and Markets Served
7.8 GlaxoSmithKline
7.8.1 GlaxoSmithKline Bio-Therapeutic Glycoproteins Production Sites and Area Served
7.8.2 Bio-Therapeutic Glycoproteins Product Introduction, Application and Specification
7.8.3 GlaxoSmithKline Bio-Therapeutic Glycoproteins Production, Revenue, Price and Gross Margin (2014-2019)
7.8.4 Main Business and Markets Served
7.9 Novartis Pharmaceuticals Corp
7.9.1 Novartis Pharmaceuticals Corp Bio-Therapeutic Glycoproteins Production Sites and Area Served
7.9.2 Bio-Therapeutic Glycoproteins Product Introduction, Application and Specification
7.9.3 Novartis Pharmaceuticals Corp Bio-Therapeutic Glycoproteins Production, Revenue, Price and Gross Margin (2014-2019)
7.9.4 Main Business and Markets Served

8 Bio-Therapeutic Glycoproteins Manufacturing Cost Analysis
8.1 Bio-Therapeutic Glycoproteins Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Bio-Therapeutic Glycoproteins
8.4 Bio-Therapeutic Glycoproteins Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.2 Bio-Therapeutic Glycoproteins Distributors List
9.3 Bio-Therapeutic Glycoproteins Customers

10 Market Dynamics
10.1 Market Trends
10.2 Opportunities
10.3 Market Drivers
10.4 Challenges
10.5 Influence Factors

11 Global Bio-Therapeutic Glycoproteins Market Forecast
11.1 Global Bio-Therapeutic Glycoproteins Production, Revenue Forecast
11.1.1 Global Bio-Therapeutic Glycoproteins Production Growth Rate Forecast (2019-2025)
11.1.2 Global Bio-Therapeutic Glycoproteins Revenue and Growth Rate Forecast (2019-2025)
11.1.3 Global Bio-Therapeutic Glycoproteins Price and Trend Forecast (2019-2025)
11.2 Global Bio-Therapeutic Glycoproteins Production Forecast by Regions (2019-2025)
11.2.1 North America Bio-Therapeutic Glycoproteins Production, Revenue Forecast (2019-2025)
11.2.2 Europe Bio-Therapeutic Glycoproteins Production, Revenue Forecast (2019-2025)
11.2.3 China Bio-Therapeutic Glycoproteins Production, Revenue Forecast (2019-2025)
11.2.4 Japan Bio-Therapeutic Glycoproteins Production, Revenue Forecast (2019-2025)
11.3 Global Bio-Therapeutic Glycoproteins Consumption Forecast by Regions (2019-2025)
11.3.1 North America Bio-Therapeutic Glycoproteins Consumption Forecast (2019-2025)
11.3.2 Europe Bio-Therapeutic Glycoproteins Consumption Forecast (2019-2025)
11.3.3 China Bio-Therapeutic Glycoproteins Consumption Forecast (2019-2025)
11.3.4 Japan Bio-Therapeutic Glycoproteins Consumption Forecast (2019-2025)
11.4 Global Bio-Therapeutic Glycoproteins Production, Revenue and Price Forecast by Type (2019-2025)
11.5 Global Bio-Therapeutic Glycoproteins Consumption Forecast by Application (2019-2025)

12 Research Findings and Conclusion

13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer